SCHEMBL27388137

SCHEMBL27388137

Cc1ccc(O)c(C)c1-c1cc(C(N)=O)cc2cn(C)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKMYT1 Q99640 15/20 0.41
▸ WEE1 P30291 4/20 0.37
▸ MYT1 Q01538 2/20 0.37
▸ CDK1 P06493 1/20 0.35
▸ CREBBP Q92793 1/20 0.35
▸ EPHB3 P54753 1/20 0.35
▸ LCK P06239 2/20 0.35
▸ LYN P07948 1/20 0.35
▸ HCK P08631 1/20 0.35
▸ FGR P09769 1/20 0.35
▸ SRC P12931 1/20 0.35
▸ EPHA1 P21709 1/20 0.35
▸ EPHB2 P29323 1/20 0.35
▸ ABL2 P42684 1/20 0.35
▸ BLK P51451 1/20 0.35
▸ EPHB4 P54760 1/20 0.35
▸ EPHB1 P54762 1/20 0.35
▸ TNK2 Q07912 1/20 0.35
▸ DDR1 Q08345 1/20 0.35
▸ PTK6 Q13882 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27388129 0.81 PKMYT1 (0.41) PKMYT1WEE1MYT1CDK1CREBBP
SCHEMBL27397921 0.77 PKMYT1 (0.44) PKMYT1
SCHEMBL27388136 0.76 PKMYT1 (0.41) PKMYT1WEE1MYT1CDK1CREBBP
SCHEMBL30971257 0.76 PKMYT1 (0.41) PKMYT1WEE1MYT1CDK1CREBBP
SCHEMBL27398742 0.74 PKMYT1 (0.46) PKMYT1WEE1MYT1EPHB3
SCHEMBL27388126 0.72 PKMYT1 (0.44) PKMYT1WEE1LCKLYNHCK
SCHEMBL27388124 0.71 PKMYT1 (0.41) PKMYT1WEE1MYT1CDK1CREBBP
SCHEMBL30971250 0.71 PKMYT1 (0.41) PKMYT1WEE1MYT1CDK1CREBBP
SCHEMBL31344839 0.71 PKMYT1 (0.39) PKMYT1WEE1MYT1CDK1CREBBP
SCHEMBL30971272 0.69 SYK (0.44) PKMYT1WEE1MYT1CDK1CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137671-A1 COMPOUNDS THAT INHIBIT PKMYT1 EXELIXIS, INC. (US) 2024-06-27 — — WO disclosed
Send feedback